5-MeO-DMT: Difference between revisions
From BurnZero
(Created page with "5-MeO-DMT is a psychedelic which differs from the classical psychedlics such as LSD, DMT or Psilocybin in that its mechanism of action seems to be partly mediated by evoking temporary epileptiform activity, suggesting a similarity to electroconvulsive therapy<ref>'''5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?''' (2023) Published: 11 December 2023. https://link.springer.com/article/10.1007/s00213-023-06517-1</ref>. It is also noted t...") |
mNo edit summary |
||
Line 1: | Line 1: | ||
5-MeO-DMT is a psychedelic which differs from the classical psychedlics such as LSD, DMT or Psilocybin in that its mechanism of action seems to be partly mediated by evoking temporary epileptiform activity, suggesting a similarity to electroconvulsive therapy<ref>'''5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?''' (2023) Published: 11 December 2023. https://link.springer.com/article/10.1007/s00213-023-06517-1</ref>. It is also noted that “reactivations,” the sudden re-experiencing of drug effects common after 5-MeO-DMT but not after typical psychedelics, may suggest that 5-MeO-DMT produces recurrent epileptiform activity. | 5-MeO-DMT is a psychedelic which differs from the classical psychedlics such as LSD, DMT or Psilocybin in that its mechanism of action seems to be partly mediated by evoking temporary epileptiform activity, suggesting a similarity to electroconvulsive therapy<ref>'''5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?''' (2023) Published: 11 December 2023. https://link.springer.com/article/10.1007/s00213-023-06517-1</ref>. It is also noted that “reactivations,” the sudden re-experiencing of drug effects common after 5-MeO-DMT but not after typical psychedelics, may suggest that 5-MeO-DMT produces recurrent epileptiform activity. | ||
'''References''' |
Latest revision as of 23:56, 17 December 2023
5-MeO-DMT is a psychedelic which differs from the classical psychedlics such as LSD, DMT or Psilocybin in that its mechanism of action seems to be partly mediated by evoking temporary epileptiform activity, suggesting a similarity to electroconvulsive therapy[1]. It is also noted that “reactivations,” the sudden re-experiencing of drug effects common after 5-MeO-DMT but not after typical psychedelics, may suggest that 5-MeO-DMT produces recurrent epileptiform activity.
References
- ↑ 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? (2023) Published: 11 December 2023. https://link.springer.com/article/10.1007/s00213-023-06517-1